Clinical Trials in Phoenix

Showing 5481-5500 of 16,646 trials

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

NCT02561455

The purpose of the study was to provide access to continued treatment for those who participated in other Astellas sponsored ASP2215 trials that completed the primary analysis and, had the potential to continue to derive clinical benefit from the treatment with ASP2215, and who did not meet any of the study discontinuation criteria in the present study.

Advanced Solid TumorsAcute Myeloid Leukemia

Astellas Pharma Global Development, Inc.9 participantsStarted May 2016

Phoenix, Arizona, United States • Baltimore, Maryland, United States • New York, New York, United States +4 more locations

COMPLETEDNA11 miles

Extravascular ICD Pivotal Study

NCT04060680

Pivotal Summary: The study is designed to demonstrate safety and efficacy of the Extravascular Implantable Cardioverter Defibrillator (EV ICD) System. Continued Access Summary: This study is designed to provide continued access to the Extravascular Implantable Cardioverter Defibrillator (EV ICD) System.

TachycardiaVentricular Arrythmia

Medtronic Cardiac Rhythm and Heart Failure393 participantsStarted Sep 2019

Scottsdale, Arizona, United States • La Jolla, California, United States • Redwood City, California, United States +53 more locations

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

Extravascular ICD Pivotal Study

Find Trials by Condition in Phoenix

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies